Active substances
Polyvinyl alcohol + Povidone
- SFDA 2
- Health Canada 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| OPTIFRESH OPTHALMIC SOLUTION | 1.4,0.6 %,% | Eye drops, solution · Ophthalmic use | 1 Dropper Container | SAR 19.00 | Generic · OTC | Jamjoom Pharmaceuticals Factory Company | Valid |
| REFRESH EYE DROPS | 1.4, 0.6 % | Eye drops, solution · Ophthalmic use | 30 Dropper Container | SAR 15.40 | NCE · OTC | ALLERGAN PHARMACEUTICALS LTD | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
MUCOPURULENT CONJUCTIVITIS - GONOCOCCAL INFECTION OF THE EYE - CHLAMYDIAL CONJUNCTIVITIS; OCULAR ROSACEA; VIRAL CONJUNCTIVITS, HERPESVIRAL KERATITIS, HERPESVIRAL CONJUNCTIVITIS, VARICELLA KERATITIS, ZOSTER CONJUNCTIVITIS, ZOSTER KERATITIS, MEASLES KERATITIS AND KERATOCONJUNCTIVITIS, VIRAL CONJUNCTIVITIS, KERATITIS
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| MURINE | 02247538 | 6 MG / ML; 5 MG / ML | SOLUTION · OPHTHALMIC | PRESTIGE BRANDS INC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.